Dermatopathology

A collaborative approach to solving difficult cases.


We are dedicated to the consultation service with a main focus on unusual cutaneous neoplastic diseases, as well as complex medical conditions involving skin. We have experts in almost all areas of anatomic pathology who are readily accessible and able to provide support as needed.

4,300+

cases seen each year


10

subspecialized pathologists



Pathology in Focus

Ruifeng (Ray) Guo, M.D., gives an overview of the dermatopathology service and the benefits of collaborating with Mayo Clinic Laboratories.

Expertise

Michael J. Camilleri, M.D.

Dermatopathologist and associate professor of Dermatology and Laboratory Medicine and Pathology

Nneka I. Comfere, M.D.

Division Chair of Derm Pathology, dermatopathologist, and professor of Dermatology and Laboratory Medicine and Pathology

Lori Erickson, M.D.

Head of Dermatopathology Section, dermatopathologist, and professor of Laboratory Medicine and Pathology

Thomas Flotte, M.D.

Dermatopathologist and professor of Laboratory Medicine and Pathology

Lawrence Gibson, M.D.

Dermatopathologist and professor of Dermatology and Laboratory Medicine and Pathology

Ruifeng (Ray) Guo, M.D., Ph.D.

Dermatopathologist and assistant professor of Dermatology and Laboratory Medicine and Pathology

Emma Johnson, M.D.

Dermatopathologist and instructor in Dermatology

Julia Lehman, M.D.

Dermatopathologist and professor of Dermatology and Laboratory Medicine and Pathology

Margot Peters, M.D.

Dermatopathologist and professor of Dermatology and Laboratory Medicine and Pathology

Carilyn Wieland, M.D

Dermatopathologist and associate professor of Dermatology and Laboratory Medicine and Pathology

Testing

MELP | Melanoma Targeted Gene Panel, Next-Generation Sequencing, Tumor

Diagnosis and management of patients with melanoma   Simultaneously interrogating multiple gene targets including BRAF (eg, V600E and V600K), GNAQ, GNA11, KIT and NRAS

CMAPT | Chromosomal Microarray, Tumor, Formalin-Fixed Paraffin-Embedded

Genomic characterization of tumor for copy number imbalances and loss of heterozygosity.   Assisting in the diagnosis malignant neoplasms

Learn more about how to order these evaluations at your institution.